申请人:Pfizer Inc.
公开号:US03932643A1
公开(公告)日:1976-01-13
Phenanthridines and phenanthridinones of the formulae ##SPC1## And the pharmaceutically-acceptable acid addition salts thereof wherein X is chloro, bromo, hydroxy, alkoxy having from 1 to 6 carbon atoms, amino, monoalkylamino, dialkylamino wherein each of the alkyl groups has from 1 to 6 carbon atoms, and benzylamino; R is hydrogen, alkyl having from 1 to 6 carbon atoms, --A--NR.sub.1 R.sub.2 wherein each of R.sub.1 and R.sub.2 is alkyl having from 1 to 6 carbon atoms and A is a divalent alkylene radical having from 2 to 6 carbon atoms; and each of Y and Z is hydrogen, and .omega.-dialkylaminoalkoxy wherein the alkyl and alkoxy groups have from 1 to 6 carbon atoms, and from 2 to 6 carbon atoms, respectively; with the proviso that when R is hydrogen or alkyl, each of Y and Z is dialkylaminoalkoxy; useful as antiviral agents and/or interferon inducers and methods for their preparation.
苯并吡啶和苯并吡啉酮的化学式如下:其中X是氯、溴、羟基、含有1至6个碳原子的烷氧基、氨基、单烷基氨基、二烷基氨基(其中每个烷基含有1至6个碳原子)和苄氨基;R是氢、含有1至6个碳原子的烷基、--A--NR₁R₂(其中R₁和R₂各自是含有1至6个碳原子的烷基,A是含有2至6个碳原子的二价烷基基团);Y和Z各自是氢,以及.ω.-二烷基氨基烷氧基(其中烷基和烷氧基含有1至6个碳原子和2至6个碳原子);但是当R是氢或烷基时,Y和Z各自是二烷基氨基烷氧基。这些化合物可用作抗病毒剂和/或干扰素诱导剂,并提供了它们的制备方法。